Sugi Predict

Sugi Predict / Compounds / SCHEMBL966913

SCHEMBL966913

SCHEMBL966913

N#Cc1nc(-c2nnc(Cc3ccc(F)cc3)o2)c(O)c2ncccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 4/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ L3MBTL1 Q9Y468 3/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ TP53 P04637 2/20 0.42
▸ NPC1 O15118 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.38
▸ APLNR P35414 2/20 0.37
▸ MAPT P10636 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ GAA P10253 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ TSHR P16473 2/20 0.37
▸ POLB P06746 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ PARP1 P09874 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13118353 0.86 NPC1 (0.49) HPGDRAB9AL3MBTL1SMN1; SMN2TP53
SCHEMBL966861 0.85 NPC1 (0.43) HPGDRAB9AL3MBTL1SMN1; SMN2TP53
SCHEMBL15197866 0.85 RAB9A (0.44) HPGDRAB9AL3MBTL1SMN1; SMN2TP53
SCHEMBL967599 0.84 L3MBTL1 (0.41) HPGDRAB9AL3MBTL1SMN1; SMN2TP53
SCHEMBL969732 0.84 RAB9A (0.44) HPGDRAB9AL3MBTL1SMN1; SMN2TP53
SCHEMBL970508 0.84 L3MBTL1 (0.42) HPGDRAB9AL3MBTL1SMN1; SMN2TP53
SCHEMBL966267 0.83 TP53 (0.42) HPGDRAB9AL3MBTL1SMN1; SMN2TP53
SCHEMBL966724 0.83 RAB9A (0.42) HPGDRAB9AL3MBTL1SMN1; SMN2TP53
SCHEMBL968387 0.83 SMN1; SMN2 (0.44) HPGDRAB9AL3MBTL1SMN1; SMN2TP53
SCHEMBL968666 0.82 RPS6KB1 (0.41) HPGDRAB9AL3MBTL1SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110003794-A1 Naphthyridine Integrase Inhibitors GSK LLC 2011-01-06 — — US disclosed
US-20110003794-A1 Naphthyridine Integrase Inhibitors GSK LLC 2011-01-06 — — US disclosed
US-20110003794-A1 Naphthyridine Integrase Inhibitors GSK LLC 2011-01-06 — — US disclosed
US-7812016-B2 Naphthyridine integrase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 2010-10-12 — — US disclosed
US-7812016-B2 Naphthyridine integrase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 2010-10-12 — — US disclosed
US-7812016-B2 Naphthyridine integrase inhibitors SMITHKLINE BEECHAM CORPORATION (US) 2010-10-12 — — US disclosed
US-20070142365-A1 Naphthyridine integrase inhibitors GSK LLC 2007-06-21 — — US disclosed
US-20070142365-A1 Naphthyridine integrase inhibitors GSK LLC 2007-06-21 — — US disclosed
US-20070142365-A1 Naphthyridine integrase inhibitors GSK LLC 2007-06-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003794-A1 Naphthyridine Integrase Inhibitors PCNA, SAMHD1, NTPCR HPGD 1538/4885RAB9A 2668/4885L3MBTL1 2808/4885
US-20070142365-A1 Naphthyridine integrase inhibitors PCNA, SAMHD1, NTPCR HPGD 1538/4885RAB9A 2668/4885L3MBTL1 2808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.